Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.8150 (0.28%) ($8.8150 - $8.8150) on Mon. Mar. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.36% (three month average) | RSI | 34 | Latest Price | $8.8150(0.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.5% a day on average for past five trading days. | Weekly Trend | BCRX declines -6.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) ARKG(30%) XLRE(24%) SDY(21%) VWO(21%) FXI(20%) | Factors Impacting BCRX price | BCRX will decline at least -1.68% in a week (0% probabilities). TLT(-10%) VIXM(-9%) UUP(-8%) VXX(-7%) PCY(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.68% (StdDev 3.36%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.46(-150.6%) | Resistance Level | $9.61 | 5 Day Moving Average | $8.84(-0.28%) | 10 Day Moving Average | $9(-2.06%) | 20 Day Moving Average | $9.61(-8.27%) | To recent high | -25.6% | To recent low | 1.4% | Market Cap | $1.555b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |